MedTrace Logo

Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints

NCT01543061 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2013-09-27

No results posted yet for this study

Summary

The objectives of the investigation will be to assess the effect of the repeated usage of a new eye drop on the tear film characteristics of silicone hydrogel contact lens wearers with contact lens related comfort problems and to quantify any potential benefit.

Conditions

  • Contact Lens Related Dry Eye Syndrome

Interventions

DEVICE

OPTIVEtm Plus

1 drop in each eye four times a day for a period of 30 (± 3) days

PROCEDURE

No treatment

One month of contact lens wear with no eye drop use

DEVICE

Blink Contacts® Eye Drops

1 drop in each eye four times a day for a period of 30 (± 3) days

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Optometric Technology Group Ltd

    lead OTHER

Principal Investigators

  • Michel Guillon, PhD · Optometric Technology Group Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-09-30
Completion
2012-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01543061 on ClinicalTrials.gov